UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

The cost of an electric vehicle (EV) mostly covers the drive motor and battery. This paper presents use of an induction motor (IM) for EV fed through a three-level voltage source converter (VSC) with ...